CHMP Backs Orphan Hybrid Drug for Wilson ' s Disease CHMP Backs Orphan Hybrid Drug for Wilson ' s Disease

Trientine tetrahydrochloride (Cuprior) is indicated for treatment of Wilson ' s disease in adults, adolescents, and children aged 5 years and older who are intolerant to D-penicillamine.International Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news